Abstract
Long-term isotopic dilution measurements of body iron may allow quantification of basal body iron balance and iron gains during an iron intervention with higher precision and accuracy than conventional iron indices. We compared body iron balance before, during, and after oral iron supplementation in women in Benin and in Switzerland. In prospective studies, Beninese (n=11) and Swiss (n=10) women previously labeled with stable iron isotopes were followed preintervention for 90-120 d, then received 50-mg iron daily for 90-120 d and were followed postintervention for 90-120 d. We used changes in blood isotopic composition to calculate iron absorption (Feabs), iron loss (Feloss), and net iron balance (Fegain). Compliance with supplementation was>90%. In Benin, during the preintervention, intervention, and postintervention periods, Fe means±SDs were as follows: 1) Feabs: 0.92±1.05, 3.75±2.07, and 0.90±0.93 mg/d; 2) Feloss: 1.46±1.95, 1.58±1.57, and 1.84±1.61 mg/d; and 3) Fegain: -0.55±1.56 mg/d, 2.17±1.81 mg/d, and -0.94±1.13 mg/d. In Switzerland, the corresponding values were: 1) 1.51±0.37, 4.09±1.52, and 0.97±0.41 mg/d; 2) 0.76±1.37, 2.54±1.43, and 2.08±1.05 mg/d; and 3) 0.75±1.37, 1.55±1.75, and -1.11±1.06 mg/d. Inflammation was low in both settings, and isotopically calculated iron balance was comparable to that calculated from changes in conventional iron indices. Without iron supplementation, Beninese women had lower long-term dietary iron absorption and higher iron losses in the preintervention period than Swiss women. During iron supplementation, both groups had high iron absorption and similar iron gains. However, there was a 3-fold increase in iron losses in the Swiss women during the supplementation and postintervention period compared with the preintervention period. Body iron isotope dilution is a promising new method for quantifying long-term body iron balance and for assessing the impact of iron interventions. The studies were registered at clinicaltrials.gov as NCT02979080 and NCT02979132, respectively.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.